Respiratory Syncytial Virus Prophylaxis With Palivizumab Is Not Associated With Improved Lung Function in Infants of Very Low Birth Weight at Early School Age-Reference-Cited by-同舟云学术

Respiratory Syncytial Virus Prophylaxis With Palivizumab Is Not Associated With Improved Lung Function in Infants of Very Low Birth Weight at Early School Age

Published:2023-11 Issue: Volume: Page:100026
ISSN:2949-7892
Container-title:CHEST Pulmonary
language:en
Short-container-title:CHEST Pulmonary

Author:

Fortmann Ingmar^ORCID,Dammann Marie-Theres^ORCID,Humberg Alexander,Kraft Hannah^ORCID,Herz Alexander^ORCID,Hanke Kathrin^ORCID,Faust Kirstin,Ricklefs Isabell,Zemlin Michael^ORCID,Liese Johannes^ORCID,Engels Geraldine,Härtel Christoph,Fortmann-Grote Carsten^ORCID,Kopp Matthias Volkmar^ORCID,Brinkmann Folke^ORCID,Herting Egbert^ORCID,Göpel Wolfgang,Stichtenoth Guido^ORCID

Funder

Bundesministerium für Bildung und Forschung

Federal Ministry of Education and Research Berlin Office

Publisher

Elsevier BV

Reference39 articles.

1. Preterm birth and sustained inflammation: consequences for the neonate;Humberg;Semin Immunopathol,2020

2. Airway function measurements and the long-term follow-up of survivors of preterm birth with and without chronic lung disease;Narang;Pediatr Pulmonol,2006

3. S2k-Leitlinie “Leitlinie zur Prophylaxe von schweren Erkrankungen durch Respiratory Syncytial Virus (RSV) bei Risikokindern.”;Liese,2018

4. Significance of respiratory syncytial virus (RSV) infection in the 1st year of life;Gross;Infection,2000

5. Short- and long-term pulmonary outcome of palivizumab in children born extremely prematurely;Prais;Chest,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is Prophylaxis With Palivizumab in Very Low Birth Weight Infants Associated With Improved Lung Function at Early School Age?;CHEST Pulmonary;2024-06

2. Keine Verbesserung der späteren Lungenfunktion nach RSV-Prophylaxe Frühgeborener;Zeitschrift für Geburtshilfe und Neonatologie;2024-02